CLINICAL_TRIALS
trial_result
· 2018-05-30
Clinical Trial Update: Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 safety and efficacy study of M2951 in rheumatoid arthritis has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2018-05-30